Table 2 Comparison of clinical and laboratory parameters according to acute kidney injury in expanded criteria donor or standard criteria donor kidney transplantation
Variables | SCD-KT | ECD-KT | ||||
|---|---|---|---|---|---|---|
Non-AKI-KT | AKI-KT | p for Trend | Non-AKI-KT | AKI-KT | p for Trend | |
Donors | n = 166 | n = 112 |  | n = 27 | n = 81 |  |
 Age at KT (years) | 38.3 ± 14.5 | 39.9 ± 11.8 | 0.329 | 61.0 ± 3.4 | 57.5 ± 5.4 | < 0.001 |
 Gender (Male: Female) | 107: 59 | 81: 31 | 0.192 | 16: 11 | 63: 18 | 0.079 |
 BMI (kg/m2) | 21.9 ± 3.7 | 23.8 ± 3.8 | < 0.001 | 23.9 ± 2.7 | 23.0 ± 2.7 | 0.156 |
 HTN, n (%) | 23 (14.5) | 13 (11.8) | 0.588 | 15 (55.6) | 35 (44.9) | 0.377 |
 DM, n (%) | 11 (6.8) | 4 (3.6) | 0.293 | 3 (11.1) | 16 (20.5) | 0.388 |
 Cause of donor death - CVA, n (%) | 114 (68.7) | 88 (78.6) | 0.076 | 23 (85.2) | 66 (81.5) | 0.777 |
Recipients | n = 196 | n = 154 |  | n = 43 | n = 116 |  |
 Age at KT (yr) | 46.3 ± 9.5 | 47.1 ± 11.0 | 0.340 | 51.9 ± 9.3 | 50.8 ± 9.5 | 0.524 |
 Gender (Male: Female) | 105: 91 | 86: 68 | 0.746 | 29: 14 | 71: 45 | 0.580 |
 BMI (kg/m2) | 22.5 ± 3.3 | 22.5 ± 2.9 | 0.681 | 23.6 ± 3.2 | 23.3 ± 3.4 | 0.681 |
 HTN, n (%) | 163 (83.2) | 134 (87.0) | 0.369 | 36 (83.7) | 103 (88.8) | 0.423 |
 DM, n (%) | 26 (13.3) | 29 (18.8) | 0.183 | 11 (25.6) | 32 (27.6) | 0.844 |
 Dialysis before KT, n (%) | 193 (98.5) | 151 (98.1) | 1.000 | 42 (97.7) | 116 (100.0) | 0.270 |
 Dialysis duration, years | 7.8 ± 4.9 | 6.8 ± 4.3 | 0.321 | 5.9 ± 4.5 | 8.3 ± 15.0 | 0.305 |
 Previous KT, n (%) | 21 (10.7) | 20 (13.0) | 0.616 | 2 (4.7) | 8 (6.9) | 0.730 |
 Cause of ESRD, n (%) |  |  | 0.013 |  |  | 0.768 |
  Glomerulonephritis | 107 (54.6) | 58 (37.7) |  | 15 (34.9) | 38 (32.8) |  |
  DM | 20 (10.2) | 25 (16.2) |  | 9 (20.9) | 27 (23.3) |  |
  HTN | 30 (15.3) | 27 (17.5) |  | 9 (20.9) | 31 (26.7) |  |
  Others | 39 (19.9) | 44 (28.6) |  | 10 (23.3) | 20 (17.2) |  |
 Cold ischemic time (min) | 243 ± 132 | 245 ± 131 | 0.927 | 235 ± 99 | 242 ± 115 | 0.716 |
 HLA mismatch number | 3.6 ± 1.5 | 3.8 ± 1.2 | 0.241 | 3.6 ± 1.6 | 3.8 ± 1.4 | 0.442 |
 Induction, n (%) |  |  | 0.001 |  |  | 0.239 |
  Basiliximab | 169 (86.2) | 111 (72.1) |  | 34 (79.1) | 80 (69.0) |  |
  ATG | 27 (13.8) | 43 (27.9) |  | 9 (20.9) | 36 (31.0) |  |
 Main immunosuppressant, n (%) | ||||||
  Tacrolimus: Cyclosporine | 175: 20 | 141: 13 | 0.769 | 40: 3 | 113: 3 | 0.345 |
 PRA > 50% | 30 (20.8) | 22 (16.3) | 0.359 | 4 (10.5) | 16 (14.8) | 0.595 |